Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 3.
Figure 3.

ExAC v1 MTR plot with case and control missense variant distributions. The ExAC v1 MTR plots with the case-ascertained qualified pathogenic (red circles) and ExAC v2 Control Group 2 benign (blue circles) missense variants across epilepsy genes SCN1A (A,B) and KCNQ2 (C,D).

This Article

  1. Published in Advance September 1, 2017, doi: 10.1101/gr.226589.117 Genome Res. 27: 1715-1729

Preprint Server



Current Issue

  1. January 2026, 36 (1)
  1. Current Issue
  1. Alert me to new issues of Genome Research